The DOI matches its Crossref record.
Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells
Open accessAbstract
High mortality rate for metastatic melanoma is related to its resistant to the current methods of therapy. Melanogenesis is a metabolic pathway characteristic for normal and malignant melanocytes that can affect the behavior of melanoma cells or its surrounding environment. Human melanoma cells in which production of melanin pigment is dependent on tyrosine levels in medium were used for experiments. Peripheral blood mononuclear cells were derived from the buffy coats purchased from Lifeblood Biological Services. Cell pigmentation was evaluated macroscopically, and tyrosinase activity was measured spectrophotometrically. Cell proliferation and viability were measured using lactate dehydrogenase release MTT, [3 H]‐thymidine incorporation and DNA content analyses, and gene expression was measured by real time RT‐PCR. Pigmented melanoma cells were significantly less sensitive to cyclophosphamide and to killing action of IL‐2‐activated peripheral blood lymphocytes. The inhibition of melanogenesis by either blocking tyrosinase catalytic site or chelating copper ions sensitized melanoma cells towards cytotoxic action of cyclophosphamide, and amplified immunotoxic activities of IL‐2 activated lymphocytes. Exogenous L‐DOPA inhibited lymphocyte proliferation producing the cell cycle arrest in G1/0 and dramatically inhibited the production of IL‐1beta, TNF‐alpha, IL‐6 and IL‐10. Thus, the active melanogenesis could not only impair the cytotoxic action of cyclophosphamid but also has potent immunosuppressive properties. This resistance to a chemotherapeutic agent or immunotoxic activity of lymphocytes could be reverted by the action of tyrosinase inhibitors. Thus, the inhibition of melanogenesis might represent a valid therapeutic target for the management of advanced melanotic melanomas. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Slominski, A. T., Zmijewski, M. A., Skobowiat, C., Zbytek, B., Slominski, R. M., & Steketee, J. D. (2012) · Advances in Anatomy, Embryology and Cell Biology · doi:10.1007/978-3-642-19683-6 · Cited by 496
Self-citationSlominski (2012) · doi:10.1007/978-3-642-19683-6_1 · Cited by 461
L‐tyrosine and L‐dihydroxyphenylalanine as hormone‐like regulators of melanocyte functions
Slominski, A., Zmijewski, M. A., & Pawelek, J. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00898.x · Cited by 451
Self-citationKey role of CRF in the skin stress response system
Slominski, A. T., Zmijewski, M. A., Zbytek, B., Tobin, D. J., Theoharides, T. C., & Rivier, J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1092 · Cited by 400
Self-citationWhat are melanocytes really doing all day long…?
Plonka, P. M., Passeron, T., Brenner, M., Tobin, D. J., Shibahara, S., Thomas, A., Slominski, A., Kadekaro, A. L., Hershkovitz, D., Peters, E., et al. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00912.x · Cited by 297
Self-citation
Metadata
- Authors
- Slominski, A., Zbytek, B., & Slominski, R.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2008-12-09
- Volume
- 124
- Issue
- 6
- Pages
- 1470-1477
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1971565191
- Cited by
- 203
- References
- 0
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells. https://app.cochat.ai/papers/10.1002/ijc.24005
- The paper
- Slominski, A., Zbytek, B., & Slominski, R. (2009). Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells. International Journal of Cancer. https://doi.org/10.1002/ijc.24005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.